Macroamylasemia is a biochemical disorder characterized by an elevated serum amylase activity resulting from the circulation of a macromolecular complex of amylase with a serum component, often an immunoglobulin. The increased molecular weight of this complex prevents the normal renal excretion of the enzyme. A few cases of celiac patients with macroamylasemia have been published in whom the biochemical disorder disappeared after treatment with a gluten-free diet.
Background
Macroamylasemia occurs in approximately 0.4% of the general population, and about 2.5-5.9% of these patients have hyperamylasemia. Hyperamylasemia may be either an isolated, benign laboratory finding without pathological significance or it may be associated with underlying diseases, such as lymphoma, AIDS, carcinoma, liver disease and autoimmune disorders. The circulating macroamylase complexes of pancreatic or salivary amylase are bound to plasma proteins which cannot be cleared by the renal glomeruli. In most cases, the macromolecular amylase represents a complex of normal amylase and either immunoglobulin A or G and may be a specific antigen-antibody complex [1, 2] . Celiac disease is a permanent intolerance to ingested gluten that results in immunologically mediated inflammatory damage of the small intestinal mucosa. Several recent population-based serologic surveys have shown celiac disease to be a common disorder, possibly affecting 1 in 200-250 individuals in most countries studied. Only few cases of celiac disease associated with macroamylasemia have been described, and the macroamylasemia disappeared once the patients followed a gluten-free diet [3] [4] [5] [6] [7] [8] [9] . We describe a patient in whom celiac disease was the cause of persistent hyperamylasemia.
